e-learning
resources
Stockholm 2007
Monday 17.09.2007
Biology of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Formation of tumor fragment spheroids (TFS) from lung cancer,
in vitro
model as like
in vivo
K. U. Kim, Y. K. Kim, Y. M. Lee, D. J. Na, S. Uh (Seoul, Daejeon, Republic Of Korea)
Source:
Annual Congress 2007 - Biology of thoracic malignancies
Session:
Biology of thoracic malignancies
Session type:
Electronic Poster Discussion
Number:
1810
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. U. Kim, Y. K. Kim, Y. M. Lee, D. J. Na, S. Uh (Seoul, Daejeon, Republic Of Korea). Formation of tumor fragment spheroids (TFS) from lung cancer,
in vitro
model as like
in vivo
. Eur Respir J 2007; 30: Suppl. 51, 1810
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Targeting gene of insulin-like growth factor type I (IGF-I) on
in vitro
model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006
CellCollector®: A novel method for the isolation of circulating tumor cells (CTC) in vivo and ex vivo in lung cancer patients during therapy
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009
Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Humanized S.typhi flagellin (FliC) transfected non-small cell lung cancer (NSCLC) cells induce local inflammatory and necrotic changes in an experimental model
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival
Source: Eur Respir J 2009; 33: 118-126
Year: 2009
Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004
In vivo micro-imaging of apoptosis in a murine xenograft model of human lung adenocarcinoma
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Inhibitory effects of shRNA targeting twist on epithelial-mesenchymal transition and invasion ability of human lung carcinoma cell A549
in vitro
Source: Eur Respir J 2006; 28: Suppl. 50, 325s
Year: 2006
Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Small cell lung cancer Xenografts can be successfully grafted from bronchoscopy derived samples: model for lung cancer translational research
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Overall survival analysis and characterization of an EGFR mutated non small cell lung cancer (NSCLC) population
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Does expression of betatubulin 3 correlate between primary non small cells lung cancer tumor and metastases?
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
The epigenetic modulator 5-aza-2’-deoxycytidine reduces the fibrotic response of human lung fibroblasts to TGFß1 in a novel, long term, 3D cell culture system.
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept